Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C?
Byung-Cheol Song, Yoo-Kyung Cho, Hyeyoung Jwa, Eun Kwang Choi, Heung Up Kim, Hyun Joo Song, Soo-Young Na, Sun-Jin Boo, Seung Uk Jeong
Clin Mol Hepatol. 2014;20(4):355-360.   Published online 2014 Dec 24     DOI: https://doi.org/10.3350/cmh.2014.20.4.355
Citations to this article as recorded by Crossref logo
2018 Korean Association for the Study of the Liver (KASL) Clinical Practice Guidelines of Chronic Hepatitis B: What's Different?
Ji Hoon Kim
The Korean Journal of Gastroenterology.2019; 73(3): 132.     CrossRef
Management of chronic hepatitis B patients in immunetolerant phase: what latest guidelines recommend
Grace Lai-Hung Wong
Clinical and Molecular Hepatology.2018; 24(2): 108.     CrossRef